Repeated Intra-cisterna Magna Injections with Amyloid-beta Oligomers to Induce Alzheimer’s Disease in Cynomolgus Monkey ( Macaca fascicularis ): A Pilot Study
Jiyeon Cho, Jinyoung Won, Yu Gyeong Kim, Chang‐Yeop Jeon, Kyung Seob Lim, Jincheol Seo, Jung Bae Seong, Hyeon-Gu Yeo, Keonwoo Kim, M U Kim, Lee Wha Gwon, Yunkyo Jung, Thanh Thi Hai Nguyen, Jisun Min, Gahye Moon, Won Seok Choi, Sung-Hyun Park, Hwal-Yong Lee, Kang-Jin Jeong, Gyu‐Seo Bae · Experimental Neurobiology · 2026
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Experimental Neurobiology · OpenAlex · article · 2026
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder which results in cognitive decline and memory loss, characterized by the accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles in the brain. Despite numerous efforts to develop animal models of AD across various species to understand its pathological characteristics and underlying mechanisms, the model that accurately mimics the pathological phenotypes of AD remains elusive. In this study, we aimed to induce sporadic AD pathological progression in non-human primates (NHP) through the repeated administration of Aβ oligomers (AβO) via the CBCT-guided intra-cisterna manga (ICM) injection.
Cynomolgus monkeys were administered AβO twice a week for four weeks, and then euthanized one week after the final injection. We found that AβO-injected NHP developed AD pathologies, including Aβ deposition, synaptic impairment, and neuroinflammation in the CA1 area of the hippocampus. Additionally, the levels of hyperphosphorylated tau were significantly increased in the cerebrospinal fluid (CSF) of AβO-injected NHP. Our results demonstrate that repeated AβO injection via the ICM route induces several early-stage AD-like neuropathological alterations, including intracellular Aβ accumulation, tau phosphorylation, and synaptic dysfunction.
The present study indicates that repeated ICM administration of AβO could be good approach to reproduce a translational NHP model of AD, enabling the study of AD pathogenesis and pre-clinical testing of potential therapeutic candidates for AD.
Open the resolved locator · 10.5607/en25052
Metadata licence: OpenAlex metadata (CC0)